$121.510
+4.873 (+4.01%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
HALO Prediction & Forecast by Similar Chart Analysis
Alphio's HALO stock price prediction model matches the current Halozyme Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $122.52 (+0.83%). The 1-week path is $122.87 (+1.12%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Halozyme Therapeutics Inc Stock?
Halozyme Therapeutics Inc (HALO) appears to be a good buy right now, with a current price of $110.42 and a forward P/E ratio of 11.45, indicating strong earnings potential. The stock has experienced a remarkable year-to-date change of +57.05% and a one-year change of +69.02%, reflecting solid momentum. Additionally, the recent Dutch court ruling in favor of Halozyme against Merck enhances its market position and could drive further growth. However, a significant risk is the hedge fund selling, which has increased by 4215.85% over the last quarter, indicating potential market volatility.
HALO stock price ended at $121.51 on Thursday, after rising +4.01%
Halozyme Therapeutics Inc (HALO) last closed at $121.51, gaining +4.01%. These facts feed the 1-day and 1-week HALO price prediction above.
Analyst Consensus
Halozyme Therapeutics Inc (HALO): 7 buy, 2 hold, 1 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Halozyme Therapeutics Inc (HALO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches HALO, ranked by similarity.
Seasonality analysis for HALO
Historically the probability of a positive October return for HALO is 100.00%. July offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for HALO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $77.26 | $79.18 | $94.61 | -34.83% |
| Nov 2026 | $75.84 | $83.82 | $97.22 | -31.02% |
| Dec 2026 | $68.14 | $78.83 | $80.41 | -35.12% |
In 2026, Halozyme Therapeutics Inc (HALO) is projected to range from $68.14 to $97.22.
Halozyme Therapeutics Inc 2026 monthly forecast
In Oct 2026, Halozyme Therapeutics Inc is projected to average $79.18, with a low of $77.26 and high of $94.61.
In Nov 2026, Halozyme Therapeutics Inc is projected to average $83.82, with a low of $75.84 and high of $97.22.
In Dec 2026, Halozyme Therapeutics Inc is projected to average $78.83, with a low of $68.14 and high of $80.41.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.